Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (13,356,209)	$ (16,108,056)
Adjustments to reconcile net loss to cash used in operating activities:
Non-cash consideration received in licensing agreement transaction	0	(945,366)
Unrealized gain on equity investment	(359,905)	(207,068)
Interest income and accretion of discount on marketable securities	(729,119)	0
Stock-based compensation expense	1,916,518	1,324,812
Depreciation and amortization expense	144,650	73,807
Amortization of right-of-use asset	253,307	0
Accretion of lease liability	288,501	88,291
Change in operating assets and liabilities:
Prepaid expenses and other current assets	258,228	262,437
Security deposit	12,491	(4,305)
Accounts payable	(121,420)	(4,870,271)
Accrued expenses	(419,302)	299,300
Net cash used in operating activities	(12,112,260)	(20,086,419)
Cash flows from investing activities:
Purchase of marketable securities	(9,757,591)	0
Sales/maturities of marketable securities	40,000,000	0
Issuance of short-term note receivable	0	(1,000,000)
Purchases of property and equipment	(13,560)	(45,935)
Software development and other costs	0	(30,230)
Net cash provided by (used in) investing activities	30,228,849	(1,076,165)
Cash flows from financing activities:
Proceeds from exercise of options and purchases from employee stock purchase plan	66,993	33,079
Net cash provided by financing activities	66,993	33,079
Net increase (decrease) in cash, cash equivalents and restricted cash	18,183,582	(21,129,505)
Cash, cash equivalents and restricted cash, at beginning of period	46,798,599	189,728,285
Cash, cash equivalents and restricted cash, at end of period	64,982,181	168,598,780
Non-cash investing and financing activities:
Right-of-use asset in exchange for lease liability	$ 0	$ 15,779,773